“Angiotensin-Converting Enzyme Inhibitor / Angiotensin II Receptor Blocker in COVID-19: a Double-edged Sword or a Myth” (2020) Nepalese Medical Journal, 3(1), pp. 309–312. doi:10.3126/nmj.v3i1.28726.